MEDPACE HOLDINGS ($MEDP) posted quarterly earnings results on Wednesday, October 22nd. The company reported earnings of $3.86 per share, beating estimates of $3.59 by $0.27. The company also reported revenue of $659,900,000, beating estimates of $653,816,603 by $6,083,397.
You can see Quiver Quantitative's $MEDP stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
MEDPACE HOLDINGS Insider Trading Activity
MEDPACE HOLDINGS insiders have traded $MEDP stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $MEDP stock by insiders over the last 6 months:
- AUGUST J. TROENDLE (CEO) has made 0 purchases and 4 sales selling 86,500 shares for an estimated $39,989,976.
- JESSE J GEIGER (President) sold 41,801 shares for an estimated $18,940,451
- SUSAN E BURWIG (Exec. VP, Operations) has made 0 purchases and 2 sales selling 17,500 shares for an estimated $8,176,050.
- KEVIN M. BRADY (CFO & Treasurer) sold 12,000 shares for an estimated $5,450,760
- STEPHEN P EWALD (General Counsel & Corp. Secy.) sold 3,000 shares for an estimated $1,350,000
- CORNELIUS P. III MCCARTHY sold 1,662 shares for an estimated $772,896
- FRED B JR DAVENPORT sold 1,712 shares for an estimated $516,715
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MEDPACE HOLDINGS Hedge Fund Activity
We have seen 302 institutional investors add shares of MEDPACE HOLDINGS stock to their portfolio, and 280 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- INVESCO LTD. removed 734,878 shares (-61.9%) from their portfolio in Q2 2025, for an estimated $230,648,809
- BAILLIE GIFFORD & CO added 517,991 shares (+12040.7%) to their portfolio in Q2 2025, for an estimated $162,576,655
- MADISON ASSET MANAGEMENT, LLC added 287,365 shares (+2967.7%) to their portfolio in Q2 2025, for an estimated $90,192,378
- JANE STREET GROUP, LLC added 268,651 shares (+622.9%) to their portfolio in Q2 2025, for an estimated $84,318,802
- MILLENNIUM MANAGEMENT LLC added 252,169 shares (+271.8%) to their portfolio in Q2 2025, for an estimated $79,145,762
- BLACKROCK, INC. removed 223,433 shares (-8.3%) from their portfolio in Q2 2025, for an estimated $70,126,681
- MORGAN STANLEY added 188,421 shares (+62.8%) to their portfolio in Q2 2025, for an estimated $59,137,815
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MEDPACE HOLDINGS Congressional Stock Trading
Members of Congress have traded $MEDP stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $MEDP stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 07/22 and 1 sale worth up to $15,000 on 08/04.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 07/24.
- REPRESENTATIVE DAVID TAYLOR sold up to $15,000 on 07/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
MEDPACE HOLDINGS Analyst Ratings
Wall Street analysts have issued reports on $MEDP in the last several months. We have seen 1 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 10/17/2025
- UBS issued a "Sell" rating on 07/29/2025
- TD Cowen issued a "Sell" rating on 07/23/2025
To track analyst ratings and price targets for MEDPACE HOLDINGS, check out Quiver Quantitative's $MEDP forecast page.
MEDPACE HOLDINGS Price Targets
Multiple analysts have issued price targets for $MEDP recently. We have seen 9 analysts offer price targets for $MEDP in the last 6 months, with a median target of $436.0.
Here are some recent targets:
- Ann Hynes from Mizuho set a target price of $575.0 on 10/17/2025
- Luke Sergott from Barclays set a target price of $425.0 on 10/02/2025
- David Windley from Jefferies set a target price of $450.0 on 09/09/2025
- Jamie Clark from Rothschild & Co set a target price of $474.0 on 09/03/2025
- Dan Leonard from UBS set a target price of $305.0 on 07/29/2025
- Eric Coldwell from Baird set a target price of $490.0 on 07/23/2025
- Jailendra Singh from Truist Securities set a target price of $436.0 on 07/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
